SUMM4ARY
Prolyl hydroxylase activity in rectal mucosa was found to be significantly greater in 11 patients with Crohn's disease than in 11 control subjects with the irritable bowel syndrome and 16 patients with ulcerative colitis (P < 0-005). Seven of the patients with Crohn's disease had a histologically normal rectum. This abnormality in apparently normal mucosa supports the concept that Crohn's disease is a 'continuous' disease of the gastrointestinal tract. Although there was no significant difference in prolyl hydroxylase activity between control subjects and patients with ulcerative colitis, those patients with quiescent disease tended to have lower values than those with active mucosal inflammation. Prolyl hydroxylase activity could not, however, be detected in the sera of either healthy control subjects or patients with inflammatory bowel disease.
The enzyme prolyl hydroxylase hydroxylates prolyl residues in developing collagen alpha chains which enables assembly of three alpha chains to form the triple helix, tropocollagen. It has been used as an indicator of collagen synthesis in many tissues and is probably a rate-limiting step in synthesis (Cardinale and Undenfriend, 1974) . Hepatic prolyl hydroxylase activity has been shown to be increased before deposition of collagen in experimental hepatic fibrosis (Takeuchi and Prockop, 1969; McGee et al., 1974) , in alcoholic hepatitis, chronic active hepatitis, and cirrhosis (Mezey et al., 1976; Fuller et al., 1976) . One study (Stein et al., 1970) suggests that prolyl hydroxylase activity can be measured in human serum, when increased activity was found in some patients with cirrhosis, hepatitis and hepatoma.
Ileal and colonic fibrosis is frequently seen in Crohn's disease, often. leading to stricture formation and intestinal obstruction (Morson and Dawson, 1972) ; fibrosis is not a conspicuous feature of ulcerative colitis.
In this study prolyl hydroxylase activity was measured in sera and rectal mucosal biopsies from patients with Crohn's disease and ulcerative colitis, and its value in discriminating between these conditions was examined.
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Methods

PATIENTS
Twelve healthy control subjects (mean age 34-7 years), 10 patients with Crohn's disease (mean age 36-5 years), and 10 patients with ulcerative colitis (mean age 46-6 years) were investigated. Each group had an equal sex distribution and at the time of investigation half the patients with inflammatory bowel disease were assessed as having active disease.
Venous blood was taken in the morning from non-fasting subjects, separated in the cold, and on the same day the serum was assayed in duplicate for prolyl hydroxylase activity using a modification of the method described by Hutton et al., (1966 (Hutton et al., 1966; Dehm and Prockop, 1971) . The substrate was stored in 2-0 ml aliquots at -20°C and thawed before use. The same batch of substrate was used for all assays reported in this study and was dialysed against water before each assay. The ratio of proline to hydroxyproline in the substrate was determined (Bates et al., 1972) (Berg and Prockop, 1973) (Tables 1 and 2) .
Two adjacent rectal mucosal biopsies 8-10 cm from the anal margin were taken, one for routine histological examination and a second was stored at -20°C after washing in 0-1 M Tris-HCl buffer (pH 7-4). Within 48 hours the biopsy was weighed wet after thawing, homogenised at 4°C in a PotterElvehjem apparatus with 1-2 ml buffer composed of 0-05 M Tris-HCl (pH 7-4), 0-25 M sucrose, 10-5 ethylenediamine tetraacetic acid, and 10-5 M dithiothreitol (Fuller et al., 1976) . Biopsies weighed 8-0-37-1 mg and there were no significant differences in weight between control and patient groups. The homogenate was centrifuged (4°C) for 10 minutes at 12 000 rpm and the supernatant assayed immediately by the method described for serum, as prolyl hydroxylase activity of rectal mucosal biopsies was found to fall to 50% after seven days despite storage at -20°C. The protein concentration of the supernatant was determined (Lowry et al., 1951) and prolyl hydroxylase activity expressed as counts per minute per milligram of protein.
Results
PROLYL HYDROXYLASE ACTIVITY IN SERUM
Prolyl hydroxylase activity could not be detected in either the control sera or in sera from patients with active and quiescent inflammatory bowel disease. Ulcerative colitis Prolyl hydroxylase activity in rectal mucosal biopsies from 11 control subjects with the irritable bowel syndrome (mean 190-4 ± S E 71-9 cpm/mg protein) did not differ significantly from values obtained in 16 patients with ulcerative colitis, (mean 1960 ± S E 64-6 cpm/mg protein) (Fig. 1 , Table 3 ). Patients with quiescent ulcerative colitis tended to have lower prolyl hydroxylase activity (mean 120-0 ± S E 770 cpm/mg protein) than those with active disease (mean 293-7 + S E 140-0 cpm/mg protein), although this difference was not significant. One patient with quiescent disease had a higher level of prolyl hydroxylase activity (722-6 cpm/mg protein) than the others (Fig. 2) but it was noted that his disease had recently been active. There was no significant difference in prolyl hydroxylase activity between those patients receiving and those not receiving corticosteroid treatment. Crohn's disease Prolyl hydroxylase in rectal mucosal biopsies from 11 patients with Crohn's disease was significantly greater than both control subjects and colitics (mean 620-0 ± SE 129-0 cpm/mg protein P < 0 005) (Fig. 1) . In seven of the patients the sigmoidoscopic and histological appearances of the rectum were normal, although Crohn's disease was present elsewhere in the gastrointestinal tract (Fig. 2) . Prolyl hydroxylase activity in five patients receiving corticosteroid treatment tended to be lower (mean 463-4 ± S E 148-7 cpm/mg protein) than in those not receiving corticosteroids (mean 750 5 + S E 197-0 cpm/mg protein) but this difference was not significant.
'Indeterminate' colitis In four patients, three females and one male (mean age 41-75 years) at the time the biopsies were taken, clinical, radiological, and histological evidence did not distinguish definitely between Crohn's disease and ulcerative colitis. Their results are included in Fig. 1 .
Discussion
Prolyl hydroxylase activity could not be detected in the sera of healthy controls or in patients with either active or quiescent inflammatory bowel disease. We can find no record of a previous study of prolyl hydroxylase activity in the serum of patients with inflammatory bowel disease but Stein et al., (1970) healthy controls and found it raised in a variety of conditions, particularly hepatitis, cirrhosis, and hepatoma. We have also investigated patients with these hepatic disorders but were unable to confirm their findings (Farthing et al., 1977, unpublished data) .
Prolyl hydroxylase activity in rectal mucosa was found to be significantly greater in Crohn's disease than either control subjects or patients with ulcerative colitis. Seven of the patients with Crohn's disease had a histologically normal rectum. This finding supports the concept that despite normal macro-and microscopic appearances, Crohn's disease is a 'continuous' disease of the gastrointestinal tract. Quantitative histology on 'normal' rectal biopsies in Crohn's disease has demonstrated significant increases in plasma cell density (Dyer et al., 1970; Goodman et al., 1976) , in the volume of the lamina propria (Goodman et al., 1976) , and in lymphoid content (Dyer et al., 1970) . It has also been shown that there is a significant reduction in intestinal disaccharidase in jejunal biopsies from patients with Crohn's disease which was thought to be confined to the distal ileum or colon (Dunne et al., 1977) . Further evidence for this hypothesis is provided by the finding that glucosamine-synthetase activity is increased in the rectal mucosa of some patients with Crohn's disease whose rectal biopsy on routine histological examination was normal (Goodman et al., 1977) . Raised levels of glucosamine-synthetase were also found in patients with resolving ulcerative colitis. Estimation of prolyl hydroxylase would appear to offer a diagnostic advantage as increased activity was only found in Crohn's disease. This finding is consistent with the extensive fibrosis seen in Crohn's disease.
Although in this study there was no significant difference in prolyl hydroxylase activity between patients who had or had not received corticosteroids, there was a tendency for the activity to be lower in those on such treatment. There is evidence in rats that prolyl hydroxylase is decreased in many tissues after administration of triamcinolone acetate (Cutroneo et al., 1975) , although other studies suggest that inhibition of collagen synthesis by glucocorticoids is independent of prolyl hydroxylase (Oikarinen, 1977) .
This study provides further evidence that in Crohn's disease there are abnormalities in apparently normal mucosa. 
